NICE announced on 9 February 2026 the launch of its new National HealthTech Access Programme (NHAP). The NHAP is set to expand NICE’s technology appraisals programme to incorporate health technologies.
The Government published the long-awaited National Cancer Plan for England on 4 February 2026. The Plan sets out how DHSC and the NHS, will improve cancer prevention, diagnosis, treatment and research across England.
Brevia Health has been awarded the Best Healthcare Public Affairs & Market Access Consultancy in 2025.
The MHRA set out on 13 January 2026, the next phase of reforms aimed at strengthening the clinical trial landscape in the UK. These reforms come at a time of renewed momentum for clinical research.
The National Institute for Care and Excellence (NICE) announced on 16 December 2025 that Professor Jonathan Benger CBE will be the organisation’s next Chief Executive, from Friday 19 December 2025. Professor Benger replaces Dr Samantha Jones, who has held the post since 2021.
The UK Government announced on 1 December 2025 a landmark deal that is expected to benefit NHS patients by expanding access to vital medicines, strengthening the UK’s pharmaceutical supply chain, and attracting new investment into the country’s life sciences sector.
